Angiogenesis, the development of new vessels from pre-existing ones, plays a critical role in cancer progression. Endothelial cells (ECs), which lead this process, need to overcome several mechanisms attempting to keep the vascular network quiescent. To sprout and form new vessels, the first barrier that ECs have to cross is the vascular basement membrane (vBM), composed of laminins, collagen and proteoglycans 1 . Angiogenic factors, such as the well-studied vascular endothelial growth factor [2] [3] [4] (VEGF), guide sprouting angiogenesis. When quiescent vessels sense angiogenic signals, tip ECs are stimulated to invade the underlying layer of vBM that prevents sprouting. This process requires proteolytic breakdown of selected vBM proteins that can be mediated by matrix metalloproteases (MMPs), such as membrane type-1 MMP (MT1-MMP; refs 5, 6) . However, the cellular mechanisms required for this process remain largely unknown.
Podosomes and invadopodia, collectively called invadosomes, are specialized cell-matrix contacts with an inherent ability to degrade extracellular matrix (ECM) in restricted areas and are typically characterized by enrichment in F-actin and cortactin [7] [8] [9] . They are considered key structures of cells that are able to cross anatomical boundaries, such as monocyte-derived cells and transformed fibroblasts 7, 10 . Cultured ECs contain either isolated 1-µm-wide individual podosomes or 4-8-µm-wide ring-like clusters of podosomes, called podosome rosettes 7, 11, 12 . The appearance of individual podosomes and rosettes in ECs can be increased by soluble factors, such as TGF-β, or by phorbol esters 11, 12 . Although endothelial podosome rosettes have been observed in TGF-β-stimulated aortic explants 11 , definitive in vivo evidence for their existence and a functional role for such structures is still lacking.
Here, we show that endothelial rosettes are critical regulators of sprouting angiogenesis and control tumour blood vessel branching. We demonstrate how the VEGF-induced upregulation of the α 6 integrin subunit in ECs induces the formation of podosome rosettes and overcomes the vascular stabilizing and anti-angiogenic effects of the vBM laminin.
RESULTS

VEGF-A induces the assembly of podosome rosettes in ECs
Podosomes (identified by the co-localization of F-actin/cortactin at the basal side of ECs) were organized in two different structures: individual podosomes or multiple podosomes clustered into podosome rosettes 7, 11, 12 (Fig. 1a) . Both structures were rarely present in cultured ECs but their amount can be increased with phorbol-12-myristate-13-acetate (PMA) treatment 12, 13 (Fig. 1a) . We evaluated whether the number of cells carrying individual podosomes or podosome rosettes was altered in angiogenic endothelium by comparing ECs that were previously stimulated or not with VEGF-A for 24 h. The number of podosome-rosette-containing ECs gradually increased over time and was significantly higher in angiogenic than in quiescent ECs (Fig. 1b and Supplementary Fig. 1a,b) . Conversely, the number of ECs carrying individual podosomes was not influenced (Fig. 1b) . Moreover, we observed self-organizing podosome rosettes in angiogenic LifeAct-RFP-transduced 14 ECs (Supplementary Video 1). As MT1-MMP is considered the main ECM proteinase in podosomes 7, 15, 16 , we quantified the active form of MT1-MMP by flow cytometry. The amount of active MT1-MMP in angiogenic ECs gradually increased during PMA treatment ( Supplementary  Fig. 1c ) and, after 40 min, it was 1.8-fold higher in angiogenic compared with quiescent ECs (Fig. 1c) . Moreover, larger areas of gelatin degradation-previously associated with podosomes 13 -were present in cells with podosome rosettes compared with individual podosomes (Fig. 1d) .
A R T I C L E S
To investigate whether endothelial podosome rosettes were present not only in cultured angiogenic ECs but also in vascular angiogenic endothelium, we analysed mouse aortic explants ex vivo-treated with VEGF-A for 48 h (Supplementary Fig. 1d ). VEGF-A-stimulated aortae exhibited podosome rosettes, identified as circular F-actinand cortactin-containing structures localized on the basal side of the endothelial layer ( Fig. 1e and Supplementary Fig. 1d ,e). In agreement with our in vitro observation, the number of cells with rosettes significantly increased in the endothelial layer of VEGF-A-stimulated aortae compared with unstimulated samples (Fig. 1f) .
Tumour angiogenic vessels are characterized by high levels of functional endothelial podosome rosettes
To investigate the presence of podosome rosettes in adult vessels undergoing in vivo angiogenesis, we analysed several tissues: two mouse models of tumour angiogenesis-the xenograft of B16F10 melanoma 17 and the RipTag2 genetic model of pancreatic insulinoma 3 ; a mouse model of post-ischaemic angiogenesis-the hindlimb ischaemia on gastrocnemius muscles 18, 19 ; and human clinical biopsies from lung tumours where high vascularity correlates with tumour progression 20 . In all tissues we were able to detect F-actin-and cortactin-positive ring-like structures in the EC membrane in close contact with vBM ( Fig. 2a and Supplementary Fig. 2a-c) . Notably, F-actin/cortactin rings were characterized by the absence or reduction of laminin staining in vBM ( Fig. 2a and Supplementary Fig. 2d ). This suggests that vBM components could be locally degraded. Indeed, in situ zymography 21 on RipTag2 tumour slices revealed gelatinase activity in the regions that contained F-actin ring-like structures and were simultaneously devoid of laminin staining ( Fig. 2b and Supplementary Fig. 2e,f) . Podosome rosettes in tumour and ischaemic vessels had a mean diameter of (2.7 ± 0.7) µm ( Fig. 2a and Supplementary Fig. 2c ) and revealed the presence of podosomal markers, such as dynamin, phospho-FAK, phospho-cortactin and MT1-MMP ( Supplementary Fig. 3a ).
RipTag2 mice tumours are characterized by an angiogenic switch phase 3, 22 . We visualized and quantified the number of endothelial podosome rosettes in tumour vasculature at different stages of tumour progression ( Fig. 2c and Supplementary Fig. 3b ). Whereas quiescent capillaries of normal islets were characterized by a negligible level of rosettes, the density of rosettes was strongly and significantly increased during the transition from the hyperplastic to the in situ tumour stage (Fig. 2c) . Moreover, by measuring podosome rosettes in human lung tumour biopsies, we found that endothelial podosome rosette density is correlated with microvessel density and VEGF-A quantity (Fig. 2d,e and Supplementary Fig. 3c ). Therefore, it seems that tumour angiogenic endothelium is characterized by a high number of ECMdegrading podosome rosettes. α 6 β 1 integrin is essential for VEGF-induced endothelial podosome rosettes
Integrins are known to be involved in podosome formation 7, 16, [23] [24] [25] . Most of the integrins expressed in ECs were recruited in podosome rosettes of angiogenic ECs ( Fig. 3a and Supplementary Fig. 4a ). To investigate whether these integrins are functionally implicated in rosette formation, we treated angiogenic ECs with specific function blocking antibodies. The inhibition of α 1 β 1 , α 2 β 1 , α 4 β 1 , α 6 β 1 or αvβ 3 significantly impaired podosome rosette formation, suggesting a specific role for these integrins in rosette dynamics. Notably, only the α 6 β 1 inhibition completely blocked the VEGFinduced rosette formation (Fig. 3a,b) , impairing, in turn, MT1-MMP membrane localization and gelatin degradation ( Fig. 3c and Supplementary Fig. 4b ). Interestingly, individual podosomes were not affected by the anti-α 6 β 1 treatment (Supplementary Fig. 4c ). We confirmed the α 6 β 1 involvement in rosette formation by silencing the α 6 subunit ( Supplementary Fig. 4d ). Angiogenic ECs with reduced α 6 β 1 integrin levels failed to form podosome rosettes (Fig. 3d) . Furthermore, consistent with previous results 26, 27 , VEGF stimulation strongly upregulated the expression of α 6 integrin in ECs ( Supplementary Fig. 4e ), thus pointing to α 6 β 1 as a potential effector acting downstream of VEGF in the signalling pathway that drives rosette formation.
Integrin α 6 β 1 was gradually recruited in podosome rosettes during their formation ( Supplementary Fig. 5a ); we therefore speculated that α 6 β 1 levels in endothelial podosome rosettes could correlate with their stability. To test this hypothesis, we analysed the lifespan of podosomes composing the rosettes in integrin α 6 -GFP (α 6 -GFP) and LifeAct-RFP-expressing ECs. Podosomes with high levels of integrin α 6 β 1 exhibited significantly longer lifespans than podosomes with low α 6 β 1 integrin ( Fig. 3e and Supplementary Fig. 5b ), confirming a crucial role for integrin α 6 in the stability of podosomes in rosettes.
We then analysed α 6 localization in VEGF-A-stimulated aortic explants. Integrin α 6 co-localized with F-actin/cortactin ring-like structures in the basal side of the endothelial layer ( Fig. 3f and Supplementary Fig. 5c ), and lentiviral-mediated downregulation of α 6 integrin in whole aortic explants significantly impaired rosette formation ( Supplementary Fig. 5d ). Moreover, experiments with aortic explants from Tie2-dependent integrin α 6 null mice 19 showed that genetic ablation of endothelial α 6 completely suppressed the formation of endothelial rosettes (Fig. 3g) .
Laminin impairs endothelial podosome rosette formation
To gain insight into the function of α 6 β 1 integrin in rosette formation, we investigated the role of laminin, the main α 6 β 1 ligand 26 . Unexpectedly, plating ECs on laminin severely inhibited VEGF-A-induced rosette formation and strongly decreased the level of active MT1-MMP (Fig. 4a,b) , but did not reduce the number of individual podosomes ( Supplementary Fig. 6a ). On the basis of these observations, we expected that laminin ablation from vBM could increase the number of podosome rosettes in blood vessels. To directly test this hypothesis, we stimulated with VEGF-A aortic explants isolated from α 4 laminin subunit null mice 28, 29 (Lama4 −/− ). Laminin α 4 is a component of laminin-411, one of the main laminins in vBM (refs 28,29) . Genetic ablation of laminin α 4 significantly increased VEGF-A-induced formation of rosettes in ECs of aortic explants (Fig. 4c) .
Interestingly, in ECs plated on laminin, the remaining podosome rosettes contained a significantly reduced amount of α 6 β 1 integrin (Supplementary Fig. 6b ). Therefore, we evaluated whether the level of α 6 β 1 on the cell surface was modulated by laminin. We observed a pronounced reduction of membrane α 6 -GFP, but not of total α 6 -GFP, on PMA treatment in the absence of laminin ( Fig. 4d and Supplementary Fig. 6c,d) . In contrast, when ECs were plated on 
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Rosette inhibition by integrin antagonists Supplementary Fig. 4d . Mean ± s.e.m. of n = 3 independent experiments in which 250 cells were analysed per experimental point. Statistical significance was calculated using a one-way ANOVA test followed by Bonferroni-adjusted post hoc t-tests ( •• P < 0.01 versus Unstim SCRL shRNA; * * P < 0.01 versus SCRL shRNA). (e) Lifespan of the podosomes that form endothelial rosettes in α 6 -GFP-and LifeAct-RFP-transduced ECs. Graph shows the lifespan in minutes of podosomes with low or high levels of integrin α 6 detected with TIRF microscopy (90 nm of depth) in VEGF-stimulated ECs. Mean ± s.e.m. of n = 230 podosomes from 3 different cells. Statistical significance was calculated using an unpaired non-parametric Mann-Whitney test ( * * P < 0.01 versus low ITGA6). (f) Endothelial layer of a 48 h VEGF-A-stimulated aortic explant immunostained by the indicated antibodies and nuclear-stained by DAPI (blue). Inset, a podosome rosette in the basal side of the endothelial layer. Scale bar, 20 µm. (g) VEGF-A stimulation in aortic explants of Tie2-dependent α 6 null mice. Aortic explants from WT (α 6 fl/fl-Tie2Cre−) or endothelial α 6 null (α 6 fl/fl-Tie2Cre+) mice were incubated for 48 h in M199 10% FCS (unstim) or M199 10% FCS with 30 ng ml −1 of VEGF-A (48 h VEGF-A). Mean ± s.e.m. of n = 3 independent experiments in which 1,250 nuclei were analysed per experimental point. Statistical significance was calculated using two-way ANOVA test followed by Bonferroni-adjusted post hoc t-tests ( • P < 0.05 versus unstim α 6 fl/fl-Tie2Cre−; * * * P < 0.001 versus 48 h VEGF-A α 6 fl/fl-Tie2Cre−).
laminin, the levels of α 6 -GFP at the cell surface were not modulated by PMA stimulation (Fig. 4d) . Taken together, these results suggest that, when bound to α 6 β 1 , laminin blocks this integrin in plasma membrane and, in turn, inhibits rosette formation.
Laminin slows down α 6 β 1 integrin translocation from FAs to podosome rosettes
To further define the relationship between α 6 β 1 integrin dynamics and podosome rosettes, we imaged α 6 -GFP and LifeAct-RFP-transduced ECs. During PMA treatment, ECs seeded on laminin formed only classical α 6 β 1 -containing FAs (FAs), but not podosome rosettes. In the absence of laminin, α 6 β 1 was instead massively recruited into podosome rosettes that underwent dynamic cycles of continuous assembly and disassembly (Supplementary Video 2). Laminin thus favours the localization of α 6 β 1 into FAs rather than into podosome rosettes ( Supplementary Fig. 6e ).
To better characterize the reorganization of adhesion sites during rosette formation, we analysed vinculin-RFP-transfected ECs by total internal reflection fluorescence (TIRF) microscopy. Before PMA treatment, vinculin was localized into FAs ( Fig. 5a and A R T I C L E S . Mean ± s.e.m. of n = 3 independent experiments in which 260 cells were analysed per experimental point. Statistical significance was calculated using a two-way ANOVA test followed by Bonferroni-adjusted post hoc t-tests ( •• P < 0.01 versus unstimulated; * P < 0.05 versus LN (0 µg ml −1 ); * * P < 0.01 versus LN (0 µg ml −1 )). (b) Cytofluorimetric analysis of active MT1-MMP in VEGF-stimulated ECs, seeded on a gelatin coating with the indicated addition of laminin. Normalized mean ± s.e.m. of n = 3 independent experiments in which 10 5 cells were analysed per experimental point. Statistical significance was calculated using a two-way ANOVA test followed by Bonferroni-adjusted post hoc t-tests ( * P < 0.05 versus LN (0 µg ml −1 ); * * P < 0.01 versus LN (0 g ml −1 )). (c) VEGF-A stimulation in aortic explants of laminin α 4 null mice. Aortic explants from Lama4 +/+ or Lama4 −/− mice were incubated for 48 h in M199 10% FCS (unstim) or M199 10% FCS with 30 ng ml −1 of VEGF-A (48 h VEGF-A). Mean ± s.e.m. of n = 3 independent experiments in which 550 nuclei were analysed per experimental point. Statistical significance was calculated using a two-way ANOVA test followed by Bonferroni-adjusted post hoc t-tests ( •• P < 0.05 versus unstimulated Lama4 +/+ ; * P < 0.05 versus 48 h VEGF-A Lama4 +/+ ). (d) Integrin α 6 membrane localization is modulated by laminin in the substratum. The graph shows the ratio of α 6 -GFP fluorescence in the membrane (TIRF microscopy with <90 nm of deepness) and in the whole cell (epifluorescence, EPI) in the indicated periods of PMA treatment; mean ± s.e.m. of n = 30 cells from 3 independent experiments.
Supplementary Video 3). After PMA treatment, roughly all FAs disassembled and only a few focal complexes were still visible; then the formation of podosome rosettes became detectable ( Fig. 5a and Supplementary Video 3). These results suggest that FA and podosome rosette dynamics are indeed correlated phenomena. Therefore, we studied rosettes in ECs treated with drugs able to modulate FA dynamics. First, we examined whether-as previously suggested 7,9 -the formation of podosome rosettes is independent of direct de novo protein synthesis, and we found that the protein-translation inhibitor cycloheximide did not interfere with the induction of rosettes (Fig. 5b) . In contrast, the microtubule inhibitor nocodazole completely blocked the appearance of podosome rosettes. As nocodazole stabilizes FA and its ensuing removal results instead in FA disassembly 30 , we observed that nocodazole washout, besides favouring FA dismantling, significantly increased the formation of podosome rosettes on PMA treatment. Furthermore, challenging ECs with the recycling inhibitor primaquine extensively impaired the development of podosome rosettes ( Fig. 5b) and completely blocked the stimulatory effect of nocodazole washout on rosette formation (Fig. 5b) . These results support a model where FA components need to be trafficked to nascent podosome rosettes to allow the formation of the latter ( Supplementary Fig. 6f ).
The requirement for a PMA-elicited reorganization of ECM adhesions could explain why the binding of laminin to α 6 β 1 integrin, which stabilizes this integrin in FAs, inhibits podosome rosettes. To confirm this hypothesis, we forced FA disassembly in ECs seeded on laminin. Microtubule-induced FA disassembly was sufficient to rescue the inhibitory effect of laminin on rosette formation (Fig. 5c) , not affecting individual podosomes ( Supplementary Fig. 6g ). Taken together, these results suggest that the level of available α 6 β 1 integrin is a limiting factor for endothelial podosome rosette formation. We therefore analysed rosette incidence in ECs with different levels of α 6 β1 integrin and seeded on different amounts of laminin. α 6 -silenced ECs failed to form rosettes independently of laminin concentration, whereas α 6 β 1 -overexpressing ECs showed a high number of rosettes even when seeded on elevated concentrations of laminin (Fig. 5d) . Conversely, modulation of α 6 β 1 integrin levels did not affect individual podosomes ( Supplementary Fig. 6h ). Moreover, the overexpression of α 6 alone was sufficient to promote rosette formation in the absence of VEGF even in cells adhering on laminin (Fig. 5e ).
Endothelial podosome rosettes are precursors of new vessel branching points
The presence of endothelial rosettes in the angiogenic endothelium prompted us to investigate their role in sprouting angiogenesis and vessel branching. We studied the formation of podosome rosettes in the mouse aortic ring (mAR) assay 26, 31 . This ex vivo angiogenesis model is characterized by the formation of VEGF-dependent capillary-like structures producing a vBM sleeve 32 ( Supplementary  Fig. 7a ). Ring-like structures with F-actin/cortactin/MT1-MMP colocalization were detectable in angiogenic sprouts. These ECMdegradative 4-µm-diameter structures were localized in the basal side of ECs (Fig. 6a,b and Supplementary Fig. 7b ,c) and are also characterized by localization of integrin α 6 ( Supplementary Fig. 7d ). Interestingly, the levels of α 6 integrin on the surface of cells containing rosettes, but outside the rosette, were reduced compared with cells without rosettes ( Supplementary Fig. 7e,f) . This supports the hypothesis of a re-localization of α 6 from the cell surface to endothelial rosettes.
Notably, the localization of podosome rosettes in mAR sprouts was distal from the tip cell ( Fig. 6b and Supplementary Video 4), suggesting that these structures were not necessarily involved in tip cell migration, but possibly in the process of branching from pre-existing sprouts. To validate this hypothesis, we performed liveimaging studies on podosome rosettes and lateral vessel branching Supplementary Fig. 6h . Mean ± s.e.m. of n = 3 independent experiments in which 320 cells were analysed per experimental point. Statistical significance was calculated using one-way ANOVA test followed by Bonferroni-adjusted post hoc t-tests ( * P < 0.05 versus empty vector L(10 µg ml −1 ); • P < 0.05 versus empty vector L(20 µg ml −1 ). (e) Graph showing the percentages of podosome-rosette-positive ECs, seeded on gelatin-coated coverslips with 20 µg ml −1 laminin. ECs were transduced as indicated and stimulated or not with VEGF-A for 24 h. Mean ± s.e.m. of n = 3 independent experiments in which 420 cells were analysed per experimental point. Statistical significance was calculated using a two-way ANOVA test followed by Bonferroniadjusted post hoc t-tests ( * P < 0.05 versus its corresponding empty vector; • P < 0.05 versus empty vector L-VEGF-A−; # P < 0.05 versus empty vector L-VEGF-A+).
by exploiting LifeAct-EGFP-expressing transgenic mice 33 . All lateral branches analysed in our study were preceded by the formation of bona fide podosome rosettes (Fig. 6c,d and Supplementary Fig. 7f and Supplementary Videos 5 and 6). However, a modest percentage of rosettes (0.5%) effectively produced new sprouts, suggesting that the appearance of rosettes alone is not sufficient to induce lateral branching.
We then analysed mAR branching in the absence of integrin α 6 or laminin. Genetic ablation of endothelial α 6 significantly reduced both the rosette formation (Fig. 3g) and the branching incidence of angiogenic sprouts ( Fig. 6e and Supplementary Video 7) without changing the total sprouting length ( Supplementary Fig. 7g ). Conversely, branching of Lama4 −/− mARs was significantly enhanced (Fig. 6f and Supplementary Video 8) , but the sprout length was not modified (Supplementary Fig. 7h ). Moreover, the exogenous addition of laminin rescued the hyper-branched phenotype of Lama4 −/− mARs ( Fig. 6f and Supplementary Video 9) .
In vivo blocking of α 6 β 1 integrin impairs endothelial podosome rosette formation and reduces tumour vessel branching To understand the physio-pathological relevance of endothelial podosome rosettes in the angiogenic process, we treated RipTag2 mice with the anti-α 6 blocking antibody. We first tested the accessibility of anti-α 6 to endothelial podosome rosettes 26, 34 . Ten minutes after injection in RipTag2 mice, the anti-α 6 antibody was sharply localized in podosome rosettes of tumour blood vessels ( Fig. 7a and Supplementary Fig. 7i ).
To evaluate the effects of anti-α 6 on endothelial rosettes, we treated RipTag2 mice for 2 weeks by starting antibody administration at the beginning of the angiogenic stage. The blockade of α 6 β 1 integrin caused a strong reduction of podosome rosette density (Fig. 7a) and concomitantly a decrease of vessel branching (Fig. 7c) .
To confirm the results obtained with anti-α 6 treatment, we analysed rosette density in vessels of B16F10 xenograft and ischaemic tissues from endothelial α 6 integrin null mice. Genetic endothelial (e) Branching density-number of branching points divided by vascular area-of angiogenic outgrowths from WT (α 6 fl/fl-Tie2Cre−) or endothelial α 6 null (α 6 fl/fl-Tie2Cre+) mARs. Dynamical analysis of branching shown in Supplementary Video 7. Mean ± s.e.m. of n = 18 mARs, 3 mARs per mouse from 6 mice. Statistical significance was calculated using a two-way ANOVA test followed by Bonferroni-adjusted post hoc t-tests ( * P < 0.05 versus α 6 fl/flTie2Cre−). (f) Branching density of angiogenic outgrowths from laminin α 4 null mARs into collagen with or without laminin addition. Dynamical analysis of Lama4 −/− branching is shown in Supplementary Video 8 and laminin in gel in Supplementary Video 9. Mean ± s.e.m. of n = 8 mARs, 2 mARs per mouse from 4 mice. Statistical significance was calculated using a two-way ANOVA test followed by Bonferroni-adjusted post hoc t-tests ( * * * P < 0.001 versus LN (0 µg ml −1 ) WT; • P < 0.05 versus LN (0 µg ml −1 )
ablation of α 6 integrin effectively impaired podosome rosettes in both models (Fig. 7d,e) . B16F10 tumours showed that α 6 integrin ablation significantly reduced blood vessel branching in tumours (Fig. 7f) , confirming our ex vivo results (Fig. 6e) . Notably, integrin α 6 localized to podosome rosettes also in angiogenic vessels of human lung tumours (Supplementary Fig. 7l ).
DISCUSSION
In the adult organism, blood vessels are usually quiescent and rarely form new branches. ECs and mural cells share a vBM that forms a sleeve around endothelial tubules and prevents resident ECs from leaving their positions 4, 35, 36 . However, ECs are able to promptly respond to angiogenic signals. The mechanisms controlling vBM proteolytic breakdown and selection of the ECs that steer lateral branches are still poorly understood. Here, we show that angiogenic endothelium forms subcellular structures with degradative activity, called podosome rosettes, which precede the emergence of new lateral sprouts.
It is known that MMPs-including MT1-MMP-correlate with angiogenesis, by letting ECs breach the vBM and enter tissues 6, 37 . Spatial and temporal control of these proteinases is essential for an efficient sprouting. In angiogenic ECs podosome rosettes are plasma membrane regions where MT1-MMP is enriched. Indeed, it is reasonable that constrained degradation of vBM is preferable to diffuse and uncontrolled proteinase activity.
Furthermore, podosome rosettes are also adhesive structures containing integrins. Notably, in a model of BM invasion in Caenorhabditis elegans 38 , the integrin heterodimer INA-1/PAT-3-highly homologous with mammalian α 6 β 1 -is crucial for cell invasion through BM (ref. 38 ). Here we show that the assembly of podosome rosettes in ECs depends on α 6 β 1 as well, thus supporting the idea that endothelial podosome rosettes are specialized structures for vBM invasion in vertebrates. Whereas endothelial podosome rosettes are involved in the sprouting process of vessels embedded in a thick vBM, such as adult vessels, they do not play a relevant role when vBM is absent, such as during early vascular development 39, 40 . This might explain why loss of integrin α 6 , laminin α 4 or MT1-MMP does not impair vascular development in embryos, but affects pathological angiogenesis in mature tissues 6, 19, 29 . Importantly, we demonstrated that VEGF-A stimulation induces the assembly of endothelial rosettes, but does not reduce the individual podosomes. This effect largely depends on α 6 β 1 integrin, which is transcriptionally induced by VEGF-A. Recent evidence shows that both FAK and β 1 integrin are required for podosome rosette assembly and stabilization 13, 24 . However, the molecular mechanisms leading to the formation of podosome rosettes remain elusive. Here, we show that α 6 β 1 contributes to the stability of podosome rosettes and that high levels of α 6 β 1 are needed within podosome rosettes to increase their lifespans (Fig. 3e) .
The transition from a quiescent to a migratory cellular phenotype is often characterized by FA disassembly followed by the formation of invadopodia or podosomes 16, 23, 41 . Our data, showing that both disassembly of FAs and recycling of their components are necessary for rosette formation, unveil a direct link between FAs and rosettes ( Supplementary Fig. 6f ). In this context, laminin of vBM hampers rosette formation by sequestering α 6 β 1 in FAs. The upregulation of α 6 -induced by angiogenic growth factor stimulation-could overcome the anti-angiogenic effect of vBM by increasing the α 6 β 1 available for the formation of podosome rosettes, which in turn will allow vBM cleavage and angiogenesis.
The molecular actors that modulate adult vasculature geometry are poorly defined. The tortuosity and high branching index of tumour vasculature often make it 'non-functional' , characterized by an impaired blood supply 42 and interstitial hypertension 43 , which compromise drug delivery 44 . Notably, all angiogenic vessels that we analysed exhibited podosome rosettes but we could not detect them in quiescent vessels. This specific distribution suggests that endothelial podosome rosettes are determinants of angiogenic vessels. Indeed, we showed that inhibition of podosome rosette formation by α 6 β 1 blockade or genetic deletion affects vessel branching (Fig. 6e and Fig. 7c,f) . Consistently, previous evidence showed how inhibition or genetic ablation of α 6 β 1 integrin in ECs impaired tumoral and post-ischaemic angiogenesis 19, 26 . In contrast, genetic ablation of laminin α 4 -described to give hyper-branched angiogenesis in the adult animal-promotes rosette formation and enhances endothelial sprouting 29, 45 . The control exerted by α 6 β 1 integrin on tumour blood vessel branching as a consequence of podosome rosette inhibition in ECs supports the previously proposed notion of vascular normalization by suggesting endothelial podosome rosettes as a new target to normalize tumour vasculature.
In summary, this work describes the role of endothelial podosome rosettes as precursors of sprouting angiogenesis and important determinants of the vascular branching in tumour angiogenesis. We proposed a model (Fig. 7g) where quiescent vessels are characterized by low levels of α 6 β 1 integrin, recruited in FAs and bound to the vBM laminin. This hampers the formation of podosome rosettes, reducing the sprouting ability. When a tumour persistently produces VEGF, α 6 integrin is upregulated in ECs. The increased availability of α 6 β 1 integrin allows the formation and stabilization of endothelial podosome rosettes and the ensuing MMP-driven modulation of ECM that, in turn, leads vBM invasion by ECs and sprouting angiogenesis.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper
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METHODS
Cell culture and reagents. Human umbilical vein endothelial cells (ECs) were
isolated from umbilical cord vein, characterized and grown as previously described 46 . In all experiments, ECs were used between passages two and five. To overcome the intrinsic biological variability of ECs, all data are shown as the mean of three independent experiments performed with a mix of ECs from three different umbilical cords.
293T (ATCC CRL-11268), B16F10 (ATCC CRL-6475) and HeLa (ATCC CCL-2) cell lines were obtained from the American Type Culture Collection and maintained as frozen stock. All experiments were performed on cell lines that had been passaged for <6 months after thaw.
Rat monoclonal function-blocking antibody against integrin α 6 (GoH3, MAB13501), aspecific rat IgGA2 antibody, VEGF-A165 and FGF-2 were obtained from R&D Systems. Function-blocking antibody against α 1 (FB12; MAB1973Z), α 2 (BHA2.1; MAB1998Z), α 4 (P1H4; MAB16983Z), α 5 (P1D6; MAB1956Z) and αv (LM609; MAB1976Z) were obtained from Millipore. Each treatment was carried out with a final concentration of 20 µg ml −1 of azide-free antibody. Phorbol-12-myristate-13-acetate (PMA) was provided by Calbiochem. Laminin (Sigma) was isolated from Engelbreth-Holm-Swarm murine sarcoma basement membrane. Nocodazole, primaquine, cycloheximide and porcine gelatin were obtained from Sigma-Aldrich.
In vitro podosome analysis. Subconfluent ECs were cultured with M199 10% FCS for 24 h and kept with or without 30 ng ml −1 VEGF-A for 24 h. ECs were then trypsinized and allowed to adhere for 2 h in M199 20% FCS on glass coverslips, previously coated with 1% porcine gelatin for 1 h. Cell were starved with serum-free M199 for 1 h and then stimulated for 5-60 min with 10% FCS M199 plus 80 ng ml −1 of PMA. To visualize podosomes, cells were paraformaldehyde (PFA)-fixed-4% PFA in PBS-and stained with anti-cortactin antibody (4F11, 05-180, Millipore) and phalloidin. We imaged ECs using a confocal laser-scanning microscope (TCS SP5 AOBS; Leica) equipped with a ×63/1.30 HCX Plan-Apochromat oil-immersion objective. Podosome-rosette-positive cells were identified by colocalization of cortactin and F-actin in a ring-like structure. Individual-podosomepositive cells were characterized by co-localization of cortactin and F-actin in a dot-like distribution. All manual quantifications were performed in a double-blind manner.
Plasmid preparation. Lentivectors carrying short hairpin RNA (shRNA) sequences against human integrin α 6 or a scramble sequence (used as control) were purchased from the RNAi Consortium library (Sigma-Aldrich). For lentivectors carrying GFP-tagged integrin α 6 (α 6 -GFP) and LifeAct-RubyFP (LifeAct-RFP), we used the In-Fusion 2.0 CF Dry-Down PCR Cloning Kit (Clonetech). Integrin α 6 , cloned into the pWPXL lentiviral vector (Trono lab, http://tronolab.epfl.ch), was tagged with GFP, inserted in the C terminus. LifeAct-RubyFP (ref. 14) was provided by R. Wedlich-Söldner, Max Planck Institute of Biochemistry, Martinsried, Germany, and was inserted in the pLKO.1 lentiviral vector in the place of the puromycin resistance sequence. For stable transduction, ECs were infected for 12-24 h at 1-6 MOI plus 8 µg ml −1 of Polybrene and mARs for 48 h with 1 million infecting virions.
Time-lapse total internal reflection fluorescence microscopy. ECs, transfected or transduced with FP-fusion-protein constructs, were incubated at 37 • C in a 5% CO 2 humidified atmosphere on gelatin-coated glass-bottom dishes (Willco, Intracel). Time-lapse experiments were performed using a Leica DMI6000 B MC TIRF system with a ×63/1.40 NA oil-immersion objective.
Blocking antibody and synthetic drug treatment in endothelial podosome rosette formation. After 24 h of VEGF treatment, subconfluent EC were trypsinized and seeded for 2 h in M199 20% FCS on glass coverslips, previously coated with 1% porcine gelatin for 1 h. Cells were starved with serum-free M199 for 30 min and then stimulated for 30 min with 10% FCS M199 plus 80 ng ml −1 of PMA.
Treatments with specific anti-integrin blocking antibodies were performed during a 2-hour-adhesion process in M199 20% FCS. Each treatment was carried out with a final concentration of 20 µg ml −1 of azide-free antibody.
Treatments with 1.25 µg ml −1 (4 µM) of nocodazole, 50 µg ml −1 (110 µM) of primaquine or 20 µg ml −1 of cycloheximide (CHX) were performed during a 30-min PMA stimulation. In the case of nocodazole washout experiments, ECs were treated with nocodazole for 30 min during serum-free M199 starving, and then rinsed twice in PBS and treated with PMA for 30 min. CHX pretreatment for 2 h showed results comparable to CHX treatment during PMA stimulation.
Matrix degradation assay. FITC-conjugated gelatin from pig skin was prepared according to the manufacturer's instructions (Invitrogen). ECs were plated on glass coverslips coated with FITC-gelatin (1 mg ml −1 ), and were then fixed and stained with phalloidin for 20 min. The regions in which 488-gelatin was degraded were analysed using ImageJ RipTag2, endothelial ITGA6 KO and Lama4 −/− mice. Generation of RipTag2 mice as a model of pancreatic islet cell carcinogenesis has been previously reported 47 . RipTag2 mice were maintained in the C57Bl/6J background (Jackson Laboratory). From 12 weeks of age, all RipTag2 mice received 50% sugar food (Harlan Teklad) and 5% sugar water to relieve hypoglycaemia induced by the insulinsecreting tumours. LifeAct-EGFP mice were generated previously 33 , and provided by R. Wedlich-Söldner (Max-Planck Institute of Biochemistry, Martinsried, Germany) and L. M. Machesky (Beatson Institute for Cancer Research, Glasgow, UK). Mice were housed under the approval and the institutional guidelines governing the care of laboratory mice of the University of Torino Committee on Animal Research and in compliance with the international laws and policies.
Generation of α 6 floxed mice (α 6 fl/fl-Tie2Cre+) has been reported previously 19 . For mouse breeding, both combinations were used: α 6 fl/fl-Tie2Cre+ (KO) male with α 6 fl/fl-Tie2Cre− (WT) female or α 6 fl/fl-Tie2Cre− (WT) male with α 6 fl/flTie2Cre+ (KO) female. Integrin α 6 KO female mice were fertile and we did not observe any evident differences during pregnancy or in newborn number or size, as described in ref. 19 . All protocols were approved by the Regional Ethics Committee on Animal Experimentation (P2.CBV.031.07, CEEA34.CB.041.11 and CEEA34.CB.011.11) and all experiments complied with Directive 2010/63/EU of the European Parliament.
Lama4 −/− mice were generated previously 28, 29 .
Melanoma tumour subcutaneous injection. One million B16F10 melanoma cells were suspended in 100 µl of PBS and injected subcutaneously into the right flank of 8-week-old α 6 fl/flTie2Cre+ and α 6 fl/flTie2Cre− male mice. Twelve days later the mice were anaesthetized with a single intraperitoneal injection of ketamine (80 mg kg −1 ) and xylazine (16 mg kg −1 ), then killed by cervical dislocation. Tumours were collected and frozen in isopentane solution cooled in liquid nitrogen before being stored at −80 • C until immunohistological analysis.
Unilateral hindlimb ischaemia. The hindlimb ischaemia experiment was performed as previously described 19, 48 . Male mice aged 7-8 weeks were anaesthetized with a single intraperitoneal injection of ketamine (80 mg kg −1 ) and xylazine (16 mg kg −1 ). The femoral artery and vein were separated from the femoral nerve, ligated, and excised from proximal to the superficial epigastric artery to proximal to the bifurcation of the saphena and popliteal arteries. On day 14 after ischaemia induction, ischaemic and non-ischaemic gastrocnemius muscles were collected and Immunostaining. ECs plated on coated glass coverslips, whole-mount mouse aortic explants, whole-mount mARs or 30-50 µm cryosections of mice tumours were equilibrated in PBS, PAF-fixed and permeabilized with PBS 0.3% Triton X-100. For biopsy, samples from human patients, 10-µm-formalin-fixed paraffinembedded (FFPE) sections were de-waxed and permeabilized with PBS 0.3% Triton-X100. Primary antibodies-mouse anti-cortactin (1:100, 4F11; 05-180; Millipore), rabbit anti-paxillin (1:100, Y113; 04-581; Millipore), goat anti-MT1-MMP (1:100, 3G4.2; MAB1767; Millipore), rabbit anti-MT1-MMP (1:150, AB53712, Abcam), mouse anti-dynamin (1:100, E-11; sc-74532; Santa Cruz Biotechnology), rabbit anti-phospho-cortactin (1:100, Tyr 421; AB3852; Millipore), mouse anti-phospho-FAK (1:80, Tyr 397; ABT135; Chemicon), mouse anti-vinculin (1:1,000, hVIN-1; V3191; Sigma-Aldrich), mouse anti-α 1 integrin (1:100, FB12; MAB1973; Millipore), mouse anti-α 2 β 1 integrin (1:100, BHA2.1; MAB1998; Millipore), mouse anti-α 3 integrin (1:100, P1B5; MAB1952; Millipore), mouse anti-α 4 integrin (1:100, P4C2; MAB1955; Millipore), mouse anti-α 5 integrin (1:50, P1D6; MAB1956; Millipore), mouse anti-αvβ 3 integrin (1:100, LM609; MAB1976; Millipore), rat anti-α 6 integrin (1:50, GoH3; MAB13501; R&D System), mouse anti-β 4 integrin (1:100, 450-11, a gift from R. Falcioni, National Cancer Institute 'Regina Elena' , Rome, Italy), and rabbit anti-laminin (1:80, AB2034, Millipore)-were diluted in PBS 5% donkey serum and incubated overnight at 4 • C in a humidified chamber. Coverslips or specimens were washed with PBS and incubated for 30 min at room temperature with secondary antibodies and counterstained with Alexa488-conjugated phalloidin (Invitrogen) and 4 ,6-diamidino-2-phenylindole (DAPI). Coverslips or specimens were analysed using a confocal laser-scanning microscope (TCS SP5 AOBS; Leica) equipped with a ×63/1.30 HCX Plan-Apochromat oilimmersion objective. Confocal stack images were digitally post-processed with blind deconvolution algorithms.
Endothelial podosome density in tumours.
We stained tumour slices with anti-laminin (1:80, AB2034, Millipore) and anti-cortactin (4F11, 05-180, Millipore) antibody and phalloidin and performed confocal imaging with a laser-scanning microscope (TCS SP5 AOBS; Leica) equipped with a ×63/1.30 HCX Plan-Apochromat oil-immersion objective. After three-dimensional (3D) blind deconvolution algorithms, tumour vessel volumes were recognized by using laminin staining using Imaris 6.3 software (Bitplane, AG). To count endothelial podosome rosettes, several discriminating criteria were followed: endothelial podosome rosettes were identified as ring-like structures within vessels with co-staining for F-actin and cortactin, close to a region depleted in laminin staining, and with a diameter ranging between 2 and 6 µm. All manual quantifications were performed in a double-blind manner.
In situ zymography. Tissue sections (RipTag2 or human lung tumours) or wholemount mARs were fixed in acetone and immunostained as indicated. Substrate for in situ zymography was prepared by diluting DQ gelatin (0.1% in deionized H 2 O, Invitrogen) 1:50 in a reaction buffer containing PBS 5 mM CaCl 2 . Tissue sections or whole-mount mARs were incubated in a dark humidity chamber at 37 • C in gelatin solution for 2 h. Samples were then carefully rinsed with PBS and PFAfixed for 10 min in the dark. To verify the contribution of metalloproteases, control slides were pre-incubated with 20 mM EDTA or protease inhibitor mix (leupeptin, aproptin and pepstatin) for 1 h. Specimens and whole-mount mARs were analysed using a confocal laser-scanning microscope (TCS SP5 AOBS; Leica) equipped with a ×40/0.95 or ×63/1.30 HCX Plan-Apochromat oil-immersion objective. Confocal stack images were digitally post-processed with deconvolution algorithms.
Immunohistochemistry on human tissues. FFPE sections (5 µm thick) were immunostained following the manufacturer's recommendations and standard protocols with antibodies against the following antigens: mouse anti-human CD31 (JC70A; 102870; Dako) and mouse anti-human VEGF (Ab-7; MS-1467-P0; Thermo Scientific). Sections were visualized by the avidin-biotin complex immunoperoxidase method, observed with a bright-field microscope and photographed. MVD and VEGF-positive area were estimated in 20 ROIs of the tumour on CD31-or VEGF-stained sections using a customized analysis with ImageJ (NIH).
Intravenous injection of antibody and detection. Rapid accessibility of antibody was analysed as previously described 26, 50 . 25 µg of anti-α 6 (GoH3, R&D) or nonspecific IgG, diluted to 125 µl final volume with 0.9% NaCl, were injected through the tail vein. Antibodies were allowed to circulate for 10 min and the tissues were fixed by vascular perfusion. The chest was opened rapidly, and the vasculature perfused for 3 min with PFA fixative from a cannula inserted into the aorta through an incision in the left ventricle. The right atrium was incised to provide an exit for the fixative. After the perfusion, tissues were removed, stored and obtained as OCT-embedded sections. The localization of antibodies was detected by incubating sections with Alexa-647 goat anti-rat antibody, phalloidin and anti-cortactin antibody. Confocal stack images were post-processed with blind deconvolution algorithms with Autodeblur (Media Cybernetics) and ImageJ (NIH).
Therapeutic antibody treatment. The therapeutic antibody treatment was performed in RipTag2 mice as previously described 26 . In brief, the dosage regimen used was 0.125 mg of anti-α 6 integrin antibody (GoH3, R&D) per mouse through tail vein injection. Antibody treatment started when mice reached the age of 9 weeks and continued for 15 days. Control animals were treated with purified rat IgG2A (R&D) at a dose of 0.125 mg per mouse every 2 days for 2 weeks. Cohorts of 6 mice were treated for each arm of the trial study.
Vascular branching index in tumours.
The vessel branching index (also 'vessel branching incidence') is the number of manually counted branching points/vascular volume and is independent of the vascularization rate. We stained tumour slices with anti-laminin (1:80, AB2034, Millipore) or anti-CD31 (JC70A; 102870; Dako) antibody and analysed them using a confocal laser-scanning microscope (TCS SP5 AOBS; Leica) equipped with a ×20/1.40 HCX Plan-Apochromat oilimmersion objective. After maximum projection of 30-µm-slices, we manually counted branching points and divided them by a given vessel volume as described above. All manual quantifications were performed in a double-blind manner.
Ex vivo podosome stimulation in aortic explants. Aortas were explanted as previously described 26 . After isolation from fibro-adipose tissue, aortae were cut along their long axis and then sectioned in 1 mm 2 squares and then incubated for 24 h in serum-free medium with antibiotics. Aortic segments were incubated for 48 h in M199 10% FCS plus antibiotics with or without 30 ng ml −1 of VEGF-A. In the case of knockdown experiments media were supplied with Polybrene and lentiviral supernatants.
To visualize podosome-positive cells, we PFA-fixed aortic explants and stained them with anti-cortactin (4F11, 05-180, Millipore) antibody and phalloidin and imaged them using a confocal laser-scanning microscope (TCS SP5 AOBS; Leica) equipped with a ×40/0.95 HCX Plan-Apochromat oil-immersion objective. After 3D blind deconvolution algorithms (ImageJ plugins), podosome-positive cells in the endothelial layer were recognized by identifying regions of co-localization of cortactin and F-actin in ring-like structures in the endothelial layer. The endothelial layer was easily identified as ECs are not as highly stained by phalloidin as smooth muscle cells (SMCs); the endothelial layer and the SMC layer are divided by a highly autofluorescing layer of elastin; moreover, the circularity of nuclei allowed to distinguish ECs from SMCs because endothelial nuclei are circular and not elongated 11 . These criteria were previously described 11 and are summarized in Supplementary Fig. 1d . All manual quantifications were performed in a double-blind manner.
Mouse aortic ring angiogenesis assay. The mouse aortic ring (mAR) assay was performed as previously described 26, 31 with the following with modifications. After explant, mARs were incubated for 2 days in serum-free medium. Aortic explants were then kept in place on glass-bottom dishes (Willco, Intracel) with a drop of 20 µl of type-I collagen gel (from rat tail, Roche) and covered with Endothelial Basal Medium (EBM, Clonetics) 5% FCS with VEGF-A (20 ng/ml, R&D) and FGF-2 (10 ng ml −1 , R&D).
Time-lapse analysis of mAR model. LifeAct-EGFP, endothelial α 6 null and Lama4 −/− mARs were embedded in type-I collagen gel, stimulated as described previously and kept at 37 • C in a 5% CO 2 humidified atmosphere for 24-72 h on glass-bottom dishes.
LifeAct-EGFP, endothelial α 6 null or Lama4 −/− mARs were imaged with a ×20/0.75 dry objective (Leica Microsystems) with an inverted photomicroscope (DM IRB HC; Leica Microsystems) in phase-contrast or epifluorescence.
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LifeAct-EGFP mARs were imaged with a ×20/0.50 dry objective (Leica Microsystems) with a multiphoton microscope Leica TCSII SP5. Z stacks were acquired at 512 × 512 resolution, scan speed of 400 Hz, and 1 µm z-step size.
To investigate the relation between endothelial podosome rosettes and lateral sprouting, we analysed 8 lateral protrusion events from 3 different mARs. We measured the time of persistence and diameter of ring-like structures. Data obtained in LifeAct-GFP mARs were corroborated by the quantification of rosettes in fixed confocal sections of mARs identified by co-staining of cortactin (4F11, 05-180, Millipore) and F-actin. Rates of rosettes per unit length and time were calculated by knowing the duration of rosettes and assuming a uniform density over every branch of the mAR. Lateral sprouting in mARs was instead quantified in live bright-field movies, where we identified protrusions emerging from pre-existing branches and either retracting or developing into full secondary branches.
Integrin α 6 membrane localization in mARs. After 10 days of culture, live mARs were treated with the rat anti-antibody GoH3 (0.2 µg ml −1 MAB13501; R&D System) for 1 h and then PFA-fixed. The localization of the anti-a6 antibody (GoH3) was detected by whole-mount incubation with Alexa-647-conjugated goat anti-rat antibody, anti-cortactin (4F11, 05-180, Millipore) antibody, phalloidin and DAPI. We quantified the anti-α 6 antibody in cells with or without endothelial rosettes by using phalloidin and DAPI staining to distinguish the cell edges and phalloidin and cortactin for podosome rosettes (shown in Supplementary Fig. 7e ). Confocal stacks of images were quantified using ImageJ (NIH).
Image analysis. Immunostained cryosections of mouse tumours or whole-mounted mARs were imaged using a confocal laser-scanning microscope (TCS SP5 AOBS; Leica) equipped with a ×40/0.95 (z-step = 0.4 µm) or ×63/1.30 HCX PlanApochromat oil-immersion objective (z-step = 0.3 µm). To increase the signal to noise ratio, confocal images were obtained by using a high line average and a low scan speed.
To reduce optical distortions, images were filtered with blind deconvolution algorithms by means of Autodeblur (Media Cybernetics). We applied 5 iterations for light microscopy, 10 for confocal stacks, and 3 for multiphoton 4D analysis. Podosome rosettes were identified in deconvoluted stacks and checked, a posteriori, in each raw stack.
For ease of visualization, we reconstructed the 3D geometry of confocal stacks by isosurface rendering using Imaris 6.3 (Bitplane, AG). Briefly, each channel was binarized with a threshold level chosen automatically by the software.
Fluorescence image quantification. Fluorescence intensity quantification was performed using Leica Confocal Software (Leica), ImageJ (NIH) or Imaris 6.3 (Bitplane, AG). Image acquisition was performed maintaining the same laser power, gain and offset settings. In the case of in vitro experiments, we analysed 10 different cells for each experimental point, in three independent experiments. Integrin α 6 localization in podosome rosettes was detected as mean fluorescence in podosome ROIs. Podosome ROIs were manually selected by using co-localization of cortactin and phalloidin staining.
In the case of vBM fluorescence quantification in proximity of endothelial podosome rosettes, we analysed 5 different fields for each mouse. After 3D blind deconvolution algorithms, tumour vessel volumes were recognized by using isosurface of vBM staining. vBM was detected as laminin staining. Volumes of vBM were subdivided in 1,000-µm 3 -volumes. The volumes of vBM were then classified in vBM volumes with or without endothelial rosettes. Mean fluorescence of laminin staining in vessel volumes was quantified by Imaris 6.3 (Bitplane, AG).
Statistical analysis.
No statistical method was used to predetermine sample size, but the sample size was conceived to obtain a 95% confidence level and a confidence interval of 5%, which were verified a posteriori once the experiment was performed. For cells and aortic explants, we used the experiments in Fig. 1 to set the maximum (VEGF-A stimulation) and the minimum (unstimulated) for the following experiments. The animal numbers for anti-α 6 treatments and for integrin α 6 null mice experiments are based on similar experiments in the past 19, 26 . The investigators were not blinded during the treatments, but they were blinded for all image analyses and manual quantifications. The experiments were not randomized.
Data are presented as means ± standard error (s.e.m.) of three independent experiments. For in vitro assays, each experiment was performed with a mix of ECs from three different umbilical cords. For digital quantification of fluorescence in specific ROIs, we measured 6 fields per experimental point in three independent experiments. For in vivo studies, cohorts of 6 mice were treated for each arm of the anti-α 6 antibody treatment study in RipTag2 mice, cohorts of 7 mice were analysed for each arm of the B16F10 tumours in α 6 null mice and cohorts of 3 mice for ischaemic experiments in α 6 null mice. For human sample analysis, we studied 11 biopsies, three different vessels per biopsy and the measurement of 20 ROIs per slide for MVD and VEGF.
Prism (GraphPad Software) was used for analysis. Statistical analyses were performed using unpaired t-tests or, when more than two groups were assessed, by ANOVA followed by Bonferroni-adjusted post hoc t-tests. F-tests were used to determine whether groups had equal variance; if equality was not established unpaired t-tests with Welch's correction were performed. A D' Agostino-Pearson test was used to assess normality. A Mann-Whitney test was used when normality was not achieved. A Pearson test was used for correlation analyses in human tissues because all three sets (rosette densities, MVD and VEGF areas) passed the normality test. Statistical significance was achieved when P was less than 0.05.
For representative images, we repeated the experiments multiple times: (ITGA6 shRNA4 and shRNA5) . Mean ± SEM of n = 3 independent experiments (***, P < 0.001 versus shSCRL.) Statistical significance was calculated using one-way ANOVA test followed by Bonferroni adjusted post-hoc t-tests. (e) Cytofluorimetric analysis of membrane integrin α6 localization. EC were incubated for 24 h in M199 10% FCS (unstimulated) or in M199 10% FCS plus 30 ng/ml of VEGF-A (24 h VEGF-A) or for 48 h in M199 10% FCS plus 30 ng/ml of VEGF-A (48 h VEGF-A). Mean ± SEM of n = 3 independent experiments. (**, P < 0.01 versus unstimulated; ***, P < 0.001.) Statistical significance was calculated using one-way ANOVA test followed by Bonferroni adjusted post-hoc t-tests. 
